Literature DB >> 18459113

Stem cells: The root of prostate cancer?

Susan Kasper1.   

Abstract

The cancer stem cell (CSC) model states that tumors contain a reservoir of self-renewing cells that maintain the heterogeneous cell population of the tumor. These cells appear to be resistant to therapy and can therefore survive to repopulate the tumor during progression to therapy resistant disease. The biology of CSCs is still not definitive since it is difficult to isolate them from solid tumors and analyze their characteristics in vitro. Another challenge is to correlate these characteristics with tumor development and progression in vivo. Using the prostate CSC as a model, this review presents the CSC hypothesis, reviews the origin, identification and functions of prostate CSCs, and discusses the clinical implications and therapeutic challenges CSCs have for cancer therapy. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18459113     DOI: 10.1002/jcp.21489

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  19 in total

Review 1.  The genetic/metabolic transformation concept of carcinogenesis.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

2.  Modulation of rotation-induced lift force for cell filtration in a low aspect ratio microchannel.

Authors:  Jian Zhou; Premkumar Vummidi Giridhar; Susan Kasper; Ian Papautsky
Journal:  Biomicrofluidics       Date:  2014-07-30       Impact factor: 2.800

3.  Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells.

Authors:  Alpna Tyagi; Sushil Kumar; Komal Raina; Michael F Wempe; Paul D Maroni; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2019-03-03       Impact factor: 4.784

Review 4.  Targeting prostate cancer stem cells for cancer therapy.

Authors:  Guocan Wang; Zhiwei Wang; Fazlul H Sarkar; Wenyi Wei
Journal:  Discov Med       Date:  2012-02       Impact factor: 2.970

5.  Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cells.

Authors:  Haiyen E Zhau; Hui He; Christopher Y Wang; Majd Zayzafoon; Colm Morrissey; Robert L Vessella; Fray F Marshall; Leland W K Chung; Ruoxiang Wang
Journal:  Clin Cancer Res       Date:  2011-02-25       Impact factor: 12.531

6.  Novel strategies targeting cancer stem cells through phytochemicals and their analogs.

Authors:  Prasad Dandawate; Subhash Padhye; Aamir Ahmad; Fazlul H Sarkar
Journal:  Drug Deliv Transl Res       Date:  2013-04-01       Impact factor: 4.617

Review 7.  Molecular markers in prostate cancer. Part I: predicting lethality.

Authors:  Sachin Agrawal; William D Dunsmuir
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

8.  Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications.

Authors:  Sarah E Kelly; Altomare Di Benedetto; Adelaide Greco; Candace M Howard; Vincent E Sollars; Donald A Primerano; Jagan V Valluri; Pier Paolo Claudio
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

Review 9.  Genetically engineered mouse models of prostate cancer.

Authors:  Maxime Parisotto; Daniel Metzger
Journal:  Mol Oncol       Date:  2013-02-14       Impact factor: 6.603

10.  A luminal epithelial stem cell that is a cell of origin for prostate cancer.

Authors:  Xi Wang; Marianna Kruithof-de Julio; Kyriakos D Economides; David Walker; Hailong Yu; M Vivienne Halili; Ya-Ping Hu; Sandy M Price; Cory Abate-Shen; Michael M Shen
Journal:  Nature       Date:  2009-09-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.